Prime Medicine Files 8-K on Shareholder Votes and Exhibits

Ticker: PRME · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1894562

Prime Medicine, Inc. 8-K Filing Summary
FieldDetail
CompanyPrime Medicine, Inc. (PRME)
Form Type8-K
Filed DateJun 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, financial-reporting

TL;DR

Prime Medicine filed an 8-K on June 5th covering shareholder votes and financial docs.

AI Summary

Prime Medicine, Inc. filed an 8-K on June 5, 2025, reporting on matters submitted to a vote of security holders and filing financial statements and exhibits. The filing pertains to events on June 4, 2025, with the company's principal executive offices located at 60 First Street, Cambridge, MA.

Why It Matters

This filing indicates corporate actions and financial reporting updates for Prime Medicine, Inc., which could impact investor understanding of the company's governance and financial status.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate operational or financial distress.

Key Players & Entities

  • Prime Medicine, Inc. (company) — Registrant
  • June 4, 2025 (date) — Earliest event reported
  • June 5, 2025 (date) — Date of report
  • 60 First Street, Cambridge, MA 02141 (address) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing by Prime Medicine, Inc.?

The primary purpose is to report on matters submitted to a vote of security holders and to file financial statements and exhibits, as indicated by the 'Submission of Matters to a Vote of Security Holders' and 'Financial Statements and Exhibits' item information.

On what date was this 8-K report filed?

The 8-K report was filed on June 5, 2025.

What is the earliest event date reported in this filing?

The earliest event date reported is June 4, 2025.

Where are Prime Medicine, Inc.'s principal executive offices located?

Prime Medicine, Inc.'s principal executive offices are located at 60 First Street, Cambridge, MA 02141.

What is Prime Medicine, Inc.'s Standard Industrial Classification (SIC) code?

Prime Medicine, Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Prime Medicine, Inc. (PRME).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.